Aiach M - Search Results

1

Factors V leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis.

Meyer G, Emmerich J, Helley D, Arnaud E, Nicaud V, Alhenc-Gelas M, Aiach M, Fischer A, Sors H, Fiessinger JN. Meyer G, et al. Among authors: aiach m. Am J Med. 2001 Jan;110(1):12-5. doi: 10.1016/s0002-9343(00)00653-7. Am J Med. 2001. PMID: 11152859

2

[Genetic risk factors of thrombosis].

Emmerich J, Aiach M. Emmerich J, et al. Among authors: aiach m. Ann Cardiol Angeiol (Paris). 2002 Jun;51(3):129-34. doi: 10.1016/s0003-3928(02)00084-7. Ann Cardiol Angeiol (Paris). 2002. PMID: 12471642 Review. French.

3

The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations.

Ameziane N, Seguin C, Borgel D, Fumeron F, Moatti D, Alhenc-Gelas M, Grandchamp B, Aiach M, Emmerich J, de Prost D. Ameziane N, et al. Among authors: aiach m. Thromb Haemost. 2002 Aug;88(2):195-9. Thromb Haemost. 2002. PMID: 12195688

4

[Coagulation factor mutations and thrombosis].

Aiach M, Alhenc-Gelas M, Borgel D, Emmerich J, Gandrille S, Picard V. Aiach M, et al. Med Sci (Paris). 2006 Nov;22(11):985-9. doi: 10.1051/medsci/20062211985. Med Sci (Paris). 2006. PMID: 17101102 Free article. Review. French.

5

Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis.

Toulon P, Vitoux JF, Fiessinger JN, Sicard D, Aiach M. Toulon P, et al. Among authors: aiach m. Blood Coagul Fibrinolysis. 1991 Jun;2(3):435-9. Blood Coagul Fibrinolysis. 1991. PMID: 1718466

6

Mechanism of protein C deficiency in a patient with arginine 358 alpha 1-antitrypsin (Pittsburgh mutation): role in the maintenance of hemostatic balance.

Emmerich J, Alhenc-Gelas M, Gandrille S, Guichet C, Fiessinger JN, Aiach M. Emmerich J, et al. Among authors: aiach m. J Lab Clin Med. 1995 Apr;125(4):531-9. J Lab Clin Med. 1995. PMID: 7706910

7

Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group.

Alhenc-Gelas M, Jestin-Le Guernic C, Vitoux JF, Kher A, Aiach M, Fiessinger JN. Alhenc-Gelas M, et al. Among authors: aiach m. Thromb Haemost. 1994 Jun;71(6):698-702. Thromb Haemost. 1994. PMID: 7974334 Clinical Trial.

8

[Activated protein C resistance: role in venous and arterial thrombosis].

Emmerich J, Alhenc-Gelas M, Aiach M, Fiessinger JN. Emmerich J, et al. Among authors: aiach m. Arch Mal Coeur Vaiss. 1996 Jun;89(6):741-5. Arch Mal Coeur Vaiss. 1996. PMID: 8760661 Review. French.

9

Resistance to activated protein C: role in venous and arterial thrombosis.

Emmerich J, Alhenc-Gelas M, Aiach M, Fiessinger JN. Emmerich J, et al. Among authors: aiach m. Biomed Pharmacother. 1996;50(6-7):254-60. doi: 10.1016/0753-3322(96)84822-0. Biomed Pharmacother. 1996. PMID: 8952864 Review.

10

The factor V gene A4070G mutation and the risk of venous thrombosis.

Alhenc-Gelas M, Nicaud V, Gandrille S, van Dreden P, Amiral J, Aubry ML, Fiessinger JN, Emmerich J, Aiach M. Alhenc-Gelas M, et al. Among authors: aiach m. Thromb Haemost. 1999 Feb;81(2):193-7. Thromb Haemost. 1999. PMID: 10063990

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

279 results

Search Page

Filters